Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEUS
2351
DELISTED
Olympic Steel
ZEUS
| $1.47M | ﹤0.01% |
125,400
+32,700
| +35% | +$324K |
|
2352
Adecoagro
AGRO
$1.3B
| $1.47M | ﹤0.01% |
339,008
-76,123
| -18% | -$318K |
|
2353
Minerals Technologies
MTX
$2.25B
| $1.47M | ﹤0.01% |
31,300
+1,200
| +4% | +$52.5K |
|
2354
Network-1 Technologies
NTIP
$35.7M
| $1.47M | ﹤0.01% |
678,278
+19,460
| +3% | +$43.9K |
|
2355
Four Corners Property Trust
FCPT
$2.77B
| $1.47M | ﹤0.01% |
60,100
-44,700
| -43% | -$959K |
|
2356
Lesaka Technologies
LSAK
$407M
| $1.47M | ﹤0.01% |
482,122
-13,100
| -3% | -$44.1K |
|
2357
American Coastal Insurance
ACIC
$467M
| $1.46M | ﹤0.01% |
187,071
+109,644
| +142% | +$890K |
|
|
GBL
2358
DELISTED
GAMCO Investors, Inc.
GBL
| $1.46M | ﹤0.01% |
109,600
+600
| +0.6% | +$7.47K |
|
2359
Ametek
AME
$58.6B
| $1.45M | ﹤0.01% |
16,250
-82,001
| -83% | -$6.88M |
|
|
NOAH
2360
Noah Holdings
NOAH
$592M
| $1.45M | ﹤0.01% |
+56,994
| New | +$1.47M |
|
2361
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.9B
| $1.45M | ﹤0.01% |
+50,100
| New | +$1.43M |
|
2362
Cineverse
CNVS
$66.8M
| $1.45M | ﹤0.01% |
37,966
-13,380
| -26% | -$301K |
|
2363
Primoris Services
PRIM
$4.5B
| $1.45M | ﹤0.01% |
81,354
+60,854
| +297% | +$960K |
|
2364
Geospace Technologies
GEOS
$71.3M
| $1.44M | ﹤0.01% |
191,328
-13,506
| -7% | -$89.9K |
|
|
UXIN
2365
Uxin Ltd
UXIN
$260M
| $1.44M | ﹤0.01% |
10,044
+4,518
| +82% | +$676K |
|
2366
Entegris
ENTG
$24.5B
| $1.43M | ﹤0.01% |
+24,290
| New | +$1.35M |
|
2367
Five Point Holdings
FPH
$368M
| $1.43M | ﹤0.01% |
309,800
+250,800
| +425% | +$1.26M |
|
|
AC
2368
DELISTED
Associated Capital Group
AC
| $1.42M | ﹤0.01% |
38,994
-2,613
| -6% | -$93.5K |
|
|
BREW
2369
DELISTED
Craft Brew Alliance, Inc.
BREW
| $1.42M | ﹤0.01% |
92,200
+64,900
| +238% | +$989K |
|
2370
STRATTEC Security
STRT
$347M
| $1.42M | ﹤0.01% |
88,958
-9,848
| -10% | -$150K |
|
2371
Invesco Senior Loan ETF
BKLN
$6.76B
| $1.41M | ﹤0.01% |
+66,100
| New | +$1.4M |
|
2372
Vanguard Long-Term Bond ETF
BLV
$5.69B
| $1.41M | ﹤0.01% |
12,592
+6,391
| +103% | +$698K |
|
2373
Syndax Pharmaceuticals
SNDX
$1.74B
| $1.4M | ﹤0.01% |
94,700
-392,900
| -81% | -$5.98M |
|
2374
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.4B
| $1.4M | ﹤0.01% |
27,100
-44,100
| -62% | -$2.28M |
|
2375
Gran Tierra Energy
GTE
$331M
| $1.4M | ﹤0.01% |
404,379
-213,300
| -35% | -$690K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.